Key features and details | |
Cat. No. | MABL-2660 |
Name | Anti-PD-L2 mAbs |
Clone No. | AFD- 366C.9E5 |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | IHC |
Species Reactivity | Human |
Basic Information | |
Specificity | This antibody is specific for human PD-L2, and recognises an epitope in the IgV domain. |
Alternative Name | CD273; Programmed cell death 1 ligand 2; PD-1 ligand 2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; PDCD1LG2; B7DC; PDCD1L2; PD L2; 9E5 |
UniProt | Q9BQ51 |
Immunogen | This antibody was raised by immunising mice with a recombinant protein fragment corresponding to the extracellular domain of human PD-L2 (as an Ig fusion protein). |
Application Notes | This antibody has been used in the immunohistochemical detection of PD-L2 in formalin-fixed, paraffin-embedded tissue sections of Hodgkin's lymphoma tissue sections (Ansell et al, 2018; Roemer et al, 2016), primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma biopsies (Shi et al, 2014; Chong et al, 2016), non–small-cell lung cancer tumour samples (Calles et al, 2015), primary and metastatic adenoid cystic carcinoma deposits (Sridharan et al, 2016), and tonsil and colorectal carcinoma tissue samples (Masugi et al, 2017). |
Antibody First Published | Shi et al. Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated with PDCD1LG2 Copy Gain Am J Surg Pathol. 2014 Dec; 38(12): 1715–1723. PMID:25025450 |
Note on publication | The article describes the original use of this antibody. |
COA Information (For reference only, actual COA shall prevail) | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |